Related Experiment Video
Updated: Nov 25, 2025
12:03
In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis
Published on: December 9, 2016
12.7K
Proliferation Assessment by Trypan Blue Exclusion in Ewing Sarcoma
Cornelius Maximilian Funk1,2, Julian Musa3,4,5,6
1Division of Translational Pediatric Sarcoma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Methods in Molecular Biology (Clifton, N.J.)
|December 16, 2020
Summary
Assessing cell proliferation is crucial for cancer research, especially in Ewing sarcoma. Trypan blue exclusion offers a simple, cost-effective method for experimental cell proliferation studies.
Area of Science:
- Oncology
- Cell Biology
Background:
- Cell proliferation, an increase in cell number, is vital for development and tissue homeostasis.
- Its deregulation is a hallmark of cancer, necessitating accurate assessment in research.
- Ewing sarcoma (EwS) is characterized by high proliferative capacity, making proliferation assessment critical in preclinical studies.
Purpose of the Study:
- To highlight the importance of cell proliferation assessment in cancer research.
- To present trypan blue exclusion as a viable method for evaluating cell proliferation.
Main Methods:
- The study focuses on trypan blue exclusion as a method for cell proliferation assessment.
- This method is described as robust, easy-to-perform, and cost-effective.
Main Results:
- Trypan blue exclusion is a reliable technique for quantifying cell proliferation.
- Its ease of use and cost-effectiveness make it suitable for experimental settings.
Conclusions:
- Accurate assessment of cell proliferation is essential in cancer research, particularly for Ewing sarcoma.
- Trypan blue exclusion provides a practical and efficient method for this assessment in preclinical research.
